Translocation t(14; 18) has been observed in 50-85% of follicular and in 30
% of diffuse non-Hodgkin lymphomas. About half of follicle center lymphoma
(FCL) undergo histological conversion at relapse to more aggressive diffuse
large B-cell lymphoma (DLBCL). This report correlates the molecular bcl-2/
lgH rearrangement by PCR and Bcl-2 immunohistochemical (IHC) expression in
a series of high grade DLBCLs with and without FCL remnant. Twenty-three pa
raffin-embedded lymph nodes from DLBCL patients were analyzed. Eleven patie
nts showed FCL remnant (Group A) and 12, did not (Group B). Single PCR from
paraffin extracted DNA followed by Southern transfer of products, hybridis
ation with internal oligoprobes for the MBR/JH and MCR/JH bcl-2 rearrangeme
nts and IHC analysis of Bcl-2 expression, were performed. PCR analysis was
positive in 34.8% of patients. Bcl-2/IgH gene rearrangements were observed
in 8 (34%) cases and 7 (30%) showed Bcl-2 expression on large noncleaved B-
cells (centroblasts). All patients from Group A showed IHC positive reactio
n on FCL remnant (small cleaved cells) but only 2 (18%) were positive in DL
BCL areas, suggesting either the loss of the bcl-2 expression on the transf
ormed lymphoma, or, alternatively, the development of a second disease when
the first lymphoma transforms. Group B patients showed a clear correlation
between PCR and IHC studies. Our results suggest a similar frequency of t(
14; 18) in DLBCLs to that reported in Europe and USA series. The discordanc
e observed between PCR and IHC, particularly in Group A, points out the nec
essity to perform both studies in order to detect bcl-2 gene involvement in
DLBCLs.